Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients.

Journal of diabetes and its complications - 1 Jan 2000

Gazzaruso Carmine, Garzaniti Adriana, Falcone Colomba, Puija Arturo, Geroldi Diego, Giordanetti Stefano, Fratino Pietro

Abstract excerpt

The relationship between lipoprotein(a) [Lp(a)] and restenosis after intracoronary stent implantation has never been analysed in diabetic patients. The aim of the present prospective study was to evaluate whether Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes are predictors of restenosis after elective stent implantation in Type 2 diabetic patients with de novo lesions of coronary arteries. We recruited...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins
Share to Apoprotein(a)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Coronary Restenosis

Share to Diabetic Angiopathies

Share to Lipoprotein(a)

Share to Patient Selection

Share to Stents

Source

Identifiers

PMID: 12738397
DOI: 10.1016/s1056-8727(02)00192-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients.PMID 12738397Read ↗

Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?Semantic proximity Read ↗

Genetic risk factors and restenosis after percutaneous coronary interventions.Semantic proximity Read ↗

Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.Semantic proximity Read ↗

The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.Semantic proximity Read ↗

D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting.Semantic proximity Read ↗

Genetic predictive factors in restenosis.Semantic proximity Read ↗

Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.Semantic proximity Read ↗

Association of Lipoprotein(a) and Inflammation with In-Stent Restenosis Across Distinct Medication Adherence Phenotypes: An Exploratory Study Incorporating a "Natural Resistance" PopulationSemantic proximity Read ↗

Candidate genetic markers and the risk of restenosis after coronary angioplasty.Semantic proximity Read ↗

Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.Semantic proximity Read ↗

No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.Semantic proximity Read ↗

Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.